The overexpression of LPCAT1 mRNA was associated with multiple disorders, including hepatocellular carcinoma [30], endometrial cancer [31], pulmonary emphysema [65], lung carcinoma [66], epithelioid trophoblastic tumors [67], and breast carcinoma [26]. Here, LPCAT1 is linked to hepatocellular carcinoma.